Autoimmune Cytopenias
News & Literature Highlights
March 2022
-
Autoimmune Cytopenias
All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP
ASH 2021 Annual Meeting and Exposition
-
Autoimmune Cytopenias
FDA Roundup
US Food and Drug Administration
-
Autoimmune Cytopenias
Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone as First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)
ASH 2021 Annual Meeting and Exposition
February 2022
-
Autoimmune Cytopenias
Machine-Learning Model for Resistance/Relapse Prediction in Immune Thrombocytopenia Using Gut Microbiota and Function Signatures
ASH 2021 Annual Meeting and Exposition
-
Autoimmune Cytopenias
Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients With Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study
ASH 2021 Annual Meeting and Exposition
January 2022
-
Autoimmune Cytopenias
Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone as First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)
ASH 2021 Annual Meeting and Exposition
-
Autoimmune Cytopenias
Updated Phase I/II Safety and Efficacy Results for Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed/Refractory Immune Thrombocytopenia
ASH 2021 Annual Meeting and Exposition
December 2021
-
Autoimmune Cytopenias
Targeted Therapies for Immune Thrombocytic Purpura: A Meta-analysis of Randomized Controlled Trials
Annals of Hematology
-
Autoimmune Cytopenias
Thromboembolic Complications in Autoimmune Hemolytic Anemia: Retrospective Study
European Journal of Haematology
November 2021
-
Autoimmune Cytopenias
Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient With Celiac Disease
American Journal of Case Reports
-
Autoimmune Cytopenias
Novel Therapies for Immune Thrombocytopenia
British Journal of Haematology
October 2021
-
Autoimmune Cytopenias
Platelet Desialylation and TFH cells—The Novel Pathway of Immune Thrombocytopenia
Experimental Hematology & Oncology
-
Autoimmune Cytopenias
IL-6 Expression Helps Distinguish Castleman’s Disease From IgG4-Related Disease in the Lung
BMC Pulmonary Medicine
-
Autoimmune Cytopenias
Low-Dose Decitabine Modulates T-Cell Homeostasis and Restores Immune Tolerance in Immune Thrombocytopenia
Blood
September 2021
August 2021
-
Autoimmune Cytopenias
Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia: ADVANCE SC, a Global Phase 3 Clinical Trial in Progress
International Society on Thrombosis and Haemostasis 2021
-
Autoimmune Cytopenias
Time Course of Response to Fostamatinib, an Oral Spleen Tyrosine Kinase (SYK) Inhibitor for the Treatment of Immune Thrombocytopenia (ITP)
International Society on Thrombosis and Haemostasis 2021
July 2021
June 2021
-
Autoimmune Cytopenias
The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia
Journal of Clinical Medicine
-
Autoimmune Cytopenias
Practical Recommendations for the Management of Patients With ITP During the COVID-19 Pandemic
Mediterranean Journal of Hematology and Infectious Diseases
May 2021
April 2021
-
Autoimmune Cytopenias
Weathering the COVID-19 Storm: Lessons From Hematologic Cytokine Syndromes
Blood Reviews
-
Autoimmune Cytopenias
Immune Thrombocytopenic Purpura Complicated by Hepatitis C Virus–Related Membranoproliferative Glomerulonephritis After Rituximab Therapy
Internal Medicine
-
Autoimmune Cytopenias
Severe Warm Autoimmune Hemolytic Anemia in COVID-19 Managed With Least Incompatible RBC Product and Glucocorticoids
Annals of Hematology
-
Autoimmune Cytopenias
Efficacy of Recombinant Erythropoietin in Autoimmune Hemolytic Anemia: A Multicenter International Study
Haematologica
